Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

With biosimilars to AstraZeneca’s blockbuster rare blood disease med Soliris recently available in the U.S., nonprofit health ...

A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder ...

Both men and women are now just as likely to confirm gender pay gap figures, as responsibility passes from CEOs to HR ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Although Walmart does not run supermarkets in India yet, it has tech offices in cities such as Chennai and Bengaluru. The ...

"Whether bringing new therapies to market or managing teams, the pursuit of excellence drives meaningful impact." ...

Shares of obesity drug developers were volatile this week amid good news for Eli Lilly's (LLY) drug candidate orforglipron, ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.